본문 바로가기 주메뉴 바로가기

ABOUT US

Healthcare Innovation by clinical AI

About us

Healthcare Innovation by
clinical AI

Team

Dong Hoon Shin

CEO MD PhD

Donghyuk Lee CSO / PhD Business & RA strategy
Soohwa Song CTO / PhD R&D management & strategy
Myung-Jin Shin CFO / CPA Financial management & strategy
Alicia Song CMO/MS Strategic Business development & Marketin
Dohyun Kim Research Engineer / PhD Project leader
Hwan Heo Research Engineer / MS Project leader
Seongbeom Park Research Engineer / MS Project leader
Gu-Sung Kwon Patent Attorney IP strategy
Hee-Jin Park Quality Manager / MS QA/QC
Yumi Kim CRA CRA/Medical Writer
Hae-Ri Lee RA FDA/CE strategy
Joo-Hyun Lee Manager Business Management

Investor

Heuron attracted KRW 15 Billion Series B investments from Mega Investment, Aju IB Investment, and Korea Investment & Securities in 2020.

Heuron is colloborating with Parkinson's Opinion Leaders group and the Korean Movement Disorder Society(KMDS) to build a consensus in the medical society.
We are conducting joint clinical research with 10 University Hospitals with its largest number among domestic AI diagnosis companies.

Partner

  • Gachon University Gil Medical Center

  • Yonsei University Gangnam Severance Hospital

  • Kyunghee University Medical Center

  • Korea University Guro Hospital

  • Korea University Ansan Hospital

  • Hallym University Dontan Sungshim Hospital

  • The Catholic University of Korea Seoul St. Mary's Hospital

  • Asan Medical Center

  • Ajou University Hospital

  • CHA bundang Medical Center

  • Hallym University Pyeongchon Sungshim Hospital